Oct 26: Eli Lilly won FDA approval Thursday for Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active ulcerative colitis (UC), marking the companys first approved drug for a type of inflammatory bowel disease
Appetite may decrease quickly, portion sizes usually become smaller, and many patients notice they are thinking about food less often throughout the day
Significant fluctuations, if not well-controlled, can lead to diabetic retinopathy
Allergic reactions: Although rare, some individuals may experience allergic reactions, which could include rash, itching, or more serious symptoms like swelling of the face, lips, or throat (angioedema)
10.1007/s00439-005-1255-6 17
Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change